Alterations of the gut microbiota in the lupus nephritis: a systematic review

References

• Kim JW, Kwok SK, Choe JY, et al. Recent advances in our understanding of the link between the intestinal microbiota and systemic lupus erythematosus. Int J Mol Sci. 2019;20(19):1. doi:10.3390/ijms20194871.
   Web of Science ®Google Scholar
• Kiriakidou M, Ching CL. Systemic lupus erythematosus. Ann Intern Med. 2020;172(11):ITC81–13. doi:10.7326/AITC202006020.
   PubMed Web of Science ®Google Scholar
• Barber MRW, Drenkard C, Falasinnu T, et al. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17(9):515–532. doi:10.1038/s41584-021-00668-1.
   PubMed Web of Science ®Google Scholar
• Yu F, Haas M, Glassock R, et al. Redefining lupus nephritis: clinical implications of pathophysiologic subtypes. Nat Rev Nephrol. 2017;13(8):483–495. doi:10.1038/nrneph.2017.85.
   PubMed Web of Science ®Google Scholar
• Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clin J Am Soc Nephrol. 2017;12(5):825–835. doi:10.2215/CJN.05780616.
   PubMed Web of Science ®Google Scholar
• Anders HJ, Saxena R, Zhao MH, et al. Lupus nephritis. Nat Rev Dis Primers. 2020;6(1):7. doi:10.1038/s41572-019-0141-9.
   PubMed Web of Science ®Google Scholar
• Rovin BH, Adler SG, Barratt J, et al. Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases. Kidney Int. 2021;100(4):753–779. doi:10.1016/j.kint.2021.05.015.
   PubMed Web of Science ®Google Scholar
• Rahbar Saadat Y, Hejazian M, Bastami M, et al. The role of microbiota in the pathogenesis of lupus: dose it impact lupus nephritis? Pharmacol Res. 2019;139:191–198. doi:10.1016/j.phrs.2018.11.023.
   PubMed Web of Science ®Google Scholar
• Lau WL, Chang Y, Vaziri ND. The consequences of altered microbiota in immune-related chronic kidney disease. Nephrol Dial Transplant. 2021;36(10):1791–1798. doi:10.1093/ndt/gfaa087.
   PubMed Web of Science ®Google Scholar
• Shi N, Li N, Duan X, et al. Interaction between the gut microbiome and mucosal immune system. Mil Med Res. 2017;4:14. doi:10.1186/s40779-017-0122-9.
   PubMed Web of Science ®Google Scholar
• Wopereis H, Sim K, Shaw A, et al. Intestinal microbiota in infants at high risk for allergy: effects of prebiotics and role in eczema development. J Allergy Clin Immunol. 2018;141(4):1334–1342 e5. doi:10.1016/j.jaci.2017.05.054.
   PubMed Web of Science ®Google Scholar
• Cignarella F, Cantoni C, Ghezzi L, et al. Intermittent fasting confers protection in CNS autoimmunity by altering the gut microbiota. Cell Metab. 2018;27(6):1222–1235 e6. doi:10.1016/j.cmet.2018.05.006.
   PubMed Web of Science ®Google Scholar
• Mei L, Yang Z, Zhang X, et al. Sustained drug treatment alters the gut microbiota in rheumatoid arthritis. Front Immunol. 2021;12:704089. doi:10.3389/fimmu.2021.704089.
   PubMed Web of Science ®Google Scholar
• Xiang S, Qu Y, Qian S, et al. Association between systemic lupus erythematosus and disruption of gut microbiota: a meta-analysis. Lupus Sci Med. 2022;9(1):e000599. doi:10.1136/lupus-2021-000599.
   PubMed Web of Science ®Google Scholar
• Manfredo Vieira S, Hiltensperger M, Kumar V, et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science. 2018;359(6380):1156–1161. doi:10.1126/science.aar7201.
   PubMed Web of Science ®Google Scholar
• Chen Y, Lin J, Xiao L, et al. Gut microbiota in systemic lupus erythematosus: a fuse and a solution. J Autoimmun. 2022;132:102867. doi:10.1016/j.jaut.2022.102867.
   PubMed Web of Science ®Google Scholar
• Hu X, Ouyang S, Xie Y, et al. Characterizing the gut microbiota in patients with chronic kidney disease. Postgrad Med. 2020;132(6):495–505. doi:10.1080/00325481.2020.1744335.
   PubMed Web of Science ®Google Scholar
• Zhao J, Ning X, Liu B, et al. Specific alterations in gut microbiota in patients with chronic kidney disease: an updated systematic review. Ren Fail. 2021;43(1):102–112. doi:10.1080/0886022X.2020.1864404.
   PubMed Web of Science ®Google Scholar
• Evenepoel P, Poesen R, Meijers B. The gut-kidney axis. Pediatr Nephrol. 2017;32(11):2005–2014. doi:10.1007/s00467-016-3527-x.
   PubMed Web of Science ®Google Scholar
• Vaziri ND, Zhao YY, Pahl MV. Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment. Nephrol Dial Transplant. 2016;31(5):737–746. doi:10.1093/ndt/gfv095.
   PubMed Web of Science ®Google Scholar
• Honda K, Littman DR. The microbiota in adaptive immune homeostasis and disease. Nature. 2016;535(7610):75–84. doi:10.1038/nature18848.
   PubMed Web of Science ®Google Scholar
• Thaiss CA, Zmora N, Levy M, et al. The microbiome and innate immunity. Nature. 2016;535(7610):65–74. doi:10.1038/nature18847.
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605. doi:10.1007/s10654-010-9491-z.
   PubMed Web of Science ®Google Scholar
• Nikolova VL, Smith MRB, Hall LJ, et al. Perturbations in gut microbiota composition in psychiatric disorders: a review and meta-analysis. JAMA Psychiatry. 2021;78(12):1343–1354. doi:10.1001/jamapsychiatry.2021.2573.
   PubMed Web of Science ®Google Scholar
• Azzouz D, Omarbekova A, Heguy A, et al. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Ann Rheum Dis. 2019;78(7):947–956. doi:10.1136/annrheumdis-2018-214856.
   PubMed Web of Science ®Google Scholar
• Azzouz DF, Chen Z, Izmirly PM, et al. Longitudinal gut microbiome analyses and blooms of pathogenic strains during lupus disease flares. Ann Rheum Dis. 2023;82(10):1315–1327. doi:10.1136/ard-2023-223929.
   PubMed Web of Science ®Google Scholar
• Bellocchi C, Fernandez-Ochoa A, Montanelli G, et al. Identification of a shared microbiomic and metabolomic profile in systemic autoimmune diseases. J Clin Med. 2019;8(9):1291. doi:10.3390/jcm8091291.
   PubMed Web of Science ®Google Scholar
• Chen BD, Jia XM, Xu JY, et al. An autoimmunogenic and proinflammatory profile defined by the gut microbiota of patients with untreated systemic lupus erythematosus. Arthritis Rheumatol. 2021;73(2):232–243. doi:10.1002/art.41511.
   PubMed Web of Science ®Google Scholar
• Gerges MA, Esmaeel NE, Makram WK, et al. Altered profile of fecal microbiota in newly diagnosed systemic lupus erythematosus Egyptian patients. Int J Microbiol. 2021;2021:9934533–9934537. doi:10.1155/2021/9934533.
   PubMed Web of Science ®Google Scholar
• Greiling TM, Dehner C, Chen XG, et al. Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus. Sci Transl Med. 2018;10(434):eaan2306. doi:10.1126/scitranslmed.aan2306.
   PubMed Web of Science ®Google Scholar
• Hevia A, Milani C, Lopez P, et al. Intestinal dysbiosis associated with systemic lupus erythematosus. mBio. 2014;5(5):e01548-14. doi:10.1128/mBio.01548-14.
   PubMed Web of Science ®Google Scholar
• Li BZ, Wang H, Li XB, et al. Altered gut fungi in systemic lupus erythematosus – a pilot study. Front Microbiol. 2022;13:1031079. doi:10.3389/fmicb.2022.1031079.
   PubMed Web of Science ®Google Scholar
• Luo XM, Edwards MR, Mu Q, et al. Gut microbiota in human systemic lupus erythematosus and a mouse model of lupus. Appl Environ Microbiol. 2018;84(4):e02288-17. doi:10.1128/AEM.02288-17.
   Web of Science ®Google Scholar
• Rodriguez-Carrio J, Lopez P, Sanchez B, et al. Intestinal dysbiosis is associated with altered short-chain fatty acids and serum-free fatty acids in systemic lupus erythematosus. Front Immunol. 2017;8:23. doi:10.3389/fimmu.2017.00023.
   PubMed Web of Science ®Google Scholar
• Tomofuji Y, Maeda Y, Oguro-Igashira E, et al. Metagenome-wide association study revealed disease-specific landscape of the gut microbiome of systemic lupus erythematosus in Japanese. Ann Rheum Dis. 2021;80(12):1575–1583. doi:10.1136/annrheumdis-2021-220687.
   PubMed Web of Science ®Google Scholar
• van der Meulen TA, Harmsen HJM, Vila AV, et al. Shared gut, but distinct oral microbiota composition in primary Sjogren’s syndrome and systemic lupus erythematosus. J Autoimmun. 2019;97:77–87. doi:10.1016/j.jaut.2018.10.009.
   PubMed Web of Science ®Google Scholar
• Yu M, Li L, Ren Q, et al. Understanding the gut-kidney axis in antineutrophil cytoplasmic antibody-associated vasculitis: an analysis of gut microbiota composition. Front Pharmacol. 2022;13:783679. doi:10.3389/fphar.2022.783679.
   PubMed Web of Science ®Google Scholar
• Zegarra-Ruiz DF, El Beidaq A, Iniguez AJ, et al. A diet-sensitive commensal lactobacillus strain mediates TLR7-dependent systemic autoimmunity. Cell Host Microbe. 2019;25(1):113–127 e6. doi:10.1016/j.chom.2018.11.009.
   PubMed Web of Science ®Google Scholar
• Wang X, Shu Q, Song L, et al. Gut microbiota in systemic lupus erythematosus and correlation with diet and clinical manifestations. Front Med (Lausanne). 2022;9:915179. doi:10.3389/fmed.2022.915179.
   PubMed Web of Science ®Google Scholar
• Mu Q, Zhang H, Liao X, et al. Control of lupus nephritis by changes of gut microbiota. Microbiome. 2017;5(1):73. doi:10.1186/s40168-017-0300-8.
   PubMedGoogle Scholar
• Valiente GR, Munir A, Hart ML, et al. Gut dysbiosis is associated with acceleration of lupus nephritis. Sci Rep. 2022;12(1):152. doi:10.1038/s41598-021-03886-5.
   PubMed Web of Science ®Google Scholar
• Johnson BM, Gaudreau MC, Al-Gadban MM, et al. Impact of dietary deviation on disease progression and gut microbiome composition in lupus-prone SNF1 mice. Clin Exp Immunol. 2015;181(2):323–337. doi:10.1111/cei.12609.
   PubMed Web of Science ®Google Scholar
• Chancharoenthana W, Kamolratanakul S, Yiengwattananon P, et al. Enhanced lupus progression in alcohol-administered Fc gamma receptor-IIb-deficiency lupus mice, partly through leaky gut-induced inflammation. Immunol Cell Biol. 2023;101(8):746–765. doi:10.1111/imcb.12675.
   PubMed Web of Science ®Google Scholar
• Wang C, Lin Y, Chen L, et al. Gut microbiota mediated the effects of high relative humidity on lupus in female MRL/lpr mice. Adv Rheumatol. 2023;63(1):24. doi:10.1186/s42358-023-00306-2.
   PubMedGoogle Scholar
• Sanz Y, Moya-Perez A. Microbiota, inflammation and obesity. Adv Exp Med Biol. 2014;817:291–317. doi:10.1007/978-1-4939-0897-4_14.
   PubMed Web of Science ®Google Scholar
• Santisteban MM, Qi Y, Zubcevic J, et al. Hypertension-linked pathophysiological alterations in the gut. Circ Res. 2017;120(2):312–323. doi:10.1161/CIRCRESAHA.116.309006.
   PubMed Web of Science ®Google Scholar
• Lopez P, de Paz B, Rodriguez-Carrio J, et al. Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients. Sci Rep. 2016;6(1):24072. doi:10.1038/srep24072.
   PubMedGoogle Scholar
• McClain MT, Heinlen LD, Dennis GJ, et al. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med. 2005;11(1):85–89. doi:10.1038/nm1167.
   PubMed Web of Science ®Google Scholar
• Shin NR, Whon TW, Bae JW. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015;33(9):496–503. doi:10.1016/j.tibtech.2015.06.011.
   PubMed Web of Science ®Google Scholar
• He X, Sun J, Liu C, et al. Compositional alterations of gut microbiota in patients with diabetic kidney disease and type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2022;15:755–765. doi:10.2147/DMSO.S347805.
   PubMed Web of Science ®Google Scholar
• Li M, Wei L, Sun J, et al. Association of gut microbiota with idiopathic membranous nephropathy. BMC Nephrol. 2022;23(1):164. doi:10.1186/s12882-022-02797-5.
   PubMed Web of Science ®Google Scholar
• Qiu C, Yuan Z, He Z, et al. Lipopolysaccharide preparation derived from Porphyromonas gingivalis induces a weaker Immuno-Inflammatory response in BV-2 microglial cells than Escherichia coli by differentially activating TLR2/4-Mediated NF-kappaB/STAT3 signaling pathways. Front Cell Infect Microbiol. 2021;11:606986. doi:10.3389/fcimb.2021.606986.
   PubMed Web of Science ®Google Scholar
• Yao X, Huang J, Zhong H, et al. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacol Ther. 2014;141(2):125–139. doi:10.1016/j.pharmthera.2013.09.004.
   PubMed Web of Science ®Google Scholar
• Tan J, Zhong Z, Tang Y, et al. Intestinal dysbiosis featuring abundance of Streptococcus associates with Henoch-Schonlein purpura nephritis (IgA vasculitis with nephritis) in adult. BMC Nephrol. 2022;23(1):10. doi:10.1186/s12882-021-02638-x.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang HF, Li X, et al. Disordered intestinal microbes are associated with the activity of systemic lupus erythematosus. Clin Sci (Lond). 2019;133(7):821–838. doi:10.1042/CS20180841.
   PubMed Web of Science ®Google Scholar
• van den Bogert B, Meijerink M, Zoetendal EG, et al. Immunomodulatory properties of Streptococcus and Veillonella isolates from the human small intestine microbiota. PLoS One. 2014;9(12):e114277. doi:10.1371/journal.pone.0114277.
   PubMed Web of Science ®Google Scholar
• Kotzin BL, Kozora E. Anti-DNA meets NMDA in neuropsychiatric lupus. Nat Med. 2001;7(11):1175–1176. doi:10.1038/nm1101-1175.
   PubMed Web of Science ®Google Scholar
• Blank M, Barzilai O, Shoenfeld Y. Molecular mimicry and auto-immunity. Clin Rev Allergy Immunol. 2007;32(1):111–118. doi:10.1007/BF02686087.
   PubMed Web of Science ®Google Scholar
• Pisetsky DS. The role of bacterial DNA in autoantibody induction. Curr Top Microbiol Immunol. 2000;247:143–155. doi:10.1007/978-3-642-59672-8_10.
   PubMed Web of Science ®Google Scholar
• Peene I, Elewaut D. Changing the wolf from outside: how microbiota trigger systemic lupus erythematosus. Ann Rheum Dis. 2019;78(7):867–869. doi:10.1136/annrheumdis-2019-215221.
   PubMed Web of Science ®Google Scholar
• Breban M, Tap J, Leboime A, et al. Faecal microbiota study reveals specific dysbiosis in spondyloarthritis. Ann Rheum Dis. 2017;76(9):1614–1622. doi:10.1136/annrheumdis-2016-211064.
   PubMed Web of Science ®Google Scholar
• Hall AB, Yassour M, Sauk J, et al. A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients. Genome Med. 2017;9(1):103. doi:10.1186/s13073-017-0490-5.
   PubMedGoogle Scholar
• Everard A, Cani PD. Gut microbiota and GLP-1. Rev Endocr Metab Disord. 2014;15(3):189–196. doi:10.1007/s11154-014-9288-6.
   PubMed Web of Science ®Google Scholar
• Andrade-Oliveira V, Amano MT, Correa-Costa M, et al. Gut bacteria products prevent AKI induced by Ischemia-Reperfusion. J Am Soc Nephrol. 2015;26(8):1877–1888. doi:10.1681/ASN.2014030288.
   PubMed Web of Science ®Google Scholar
• Jiang S, Xie S, Lv D, et al. A reduction in the butyrate producing species roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression. Antonie Van Leeuwenhoek. 2016;109(10):1389–1396. doi:10.1007/s10482-016-0737-y.
   PubMed Web of Science ®Google Scholar
• Canfora EE, Jocken JW, Blaak EE. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol. 2015;11(10):577–591. doi:10.1038/nrendo.2015.128.
   PubMed Web of Science ®Google Scholar
• Sanchez HN, Moroney JB, Gan H, et al. B cell-intrinsic epigenetic modulation of antibody responses by dietary fiber-derived short-chain fatty acids. Nat Commun. 2020;11(1):60. doi:10.1038/s41467-019-13603-6.
   PubMed Web of Science ®Google Scholar
• Hall AV, Parbtani A, Clark WF, et al. Abrogation of MRL/lpr lupus nephritis by dietary flaxseed. Am J Kidney Dis. 1993;22(2):326–332. doi:10.1016/s0272-6386(12)70326-8.
   PubMed Web of Science ®Google Scholar
• Li D, Pan Y, Xia X, et al. Bacteroides fragilis alleviates the symptoms of lupus nephritis via regulating CD1d and CD86 expressions in B cells. Eur J Pharmacol. 2020;884:173421. doi:10.1016/j.ejphar.2020.173421.
   PubMed Web of Science ®Google Scholar
• Chen D, Wu J, Jin D, et al. Fecal microbiota transplantation in cancer management: current status and perspectives. Int J Cancer. 2019;145(8):2021–2031. doi:10.1002/ijc.32003.
   PubMed Web of Science ®Google Scholar
• Zhao J, Bai M, Yang X, et al. Alleviation of refractory IgA nephropathy by intensive fecal microbiota transplantation: the first case reports. Ren Fail. 2021;43(1):928–933. doi:10.1080/0886022X.2021.1936038.
   PubMed Web of Science ®Google Scholar
• Huang C, Yi P, Zhu M, et al. Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: an EXPLORER trial. J Autoimmun. 2022;130:102844. doi:10.1016/j.jaut.2022.102844.
   PubMed Web of Science ®Google Scholar